PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
-22.73%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.29B
AUM Growth
+$1.29B
(-28%)
Cap. Flow
-$34M
Cap. Flow
% of AUM
-2.64%
Top 10 Holdings %
Top 10 Hldgs %
71.19%
Holding
44
New
1
Increased
10
Reduced
7
Closed
–
Top Buys
| 1 |
Acadia Pharmaceuticals
ACAD
|
$13.6M |
| 2 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$1.7M |
| 3 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$1.65M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
$976K |
| 5 |
United Therapeutics
UTHR
|
$780K |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$53.4M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$1.66M |
| 3 |
STAAR Surgical
STAA
|
$184K |
| 4 |
Karyopharm Therapeutics
KPTI
|
$129K |
| 5 |
EPZM
Epizyme, Inc
EPZM
|
$66.7K |
Sector Composition
| 1 | Healthcare | 81.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $221M | 17.12% | 2,325,959 -563,546 | -20% | -$53.4M |
|
|
2
United Therapeutics
UTHR
$13.8B
| $170M | 13.2% | 1,525,654 +7,000 | +0.5% | +$780K |
|
|
ANAC
3
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $119M | 9.21% | 2,219,042 +31,800 | +1% | +$1.7M |
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $111M | 8.58% | 1,340,347 +3,500 | +0.3% | +$289K |
|
|
AMAG
5
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $68M | 5.28% | 2,906,194 +70,402 | +2% | +$1.65M |
|
|
CLVS
6
DELISTED
Clovis Oncology, Inc.
CLVS
| $66.5M | 5.16% | 3,461,365 -86,354 | -2% | -$1.66M |
|
7
Insmed
INSM
$28.8B
| $60.7M | 4.71% | 4,790,800 | – | – |
|
|
WMGI
8
DELISTED
Wright Medical Group Inc
WMGI
| $36.4M | 2.82% | 2,190,957 +58,800 | +3% | +$976K |
|
9
Vanda Pharmaceuticals
VNDA
$279M
| $33.7M | 2.62% | 4,030,908 | – | – |
|
|
EPZM
10
DELISTED
Epizyme, Inc
EPZM
| $32.2M | 2.5% | 2,655,479 -5,500 | -0.2% | -$66.7K |
|
11
Amicus Therapeutics
FOLD
$2.34B
| $30M | 2.33% | 3,551,173 | – | – |
|
12
Prothena Corp
PRTA
$441M
| $28.6M | 2.22% | 695,518 | – | – |
|
13
Gilead Sciences
GILD
$140B
| $27.8M | 2.16% | 302,900 | – | – |
|
|
14
Karyopharm Therapeutics
KPTI
$61.7M
| $27.6M | 2.15% | 3,098,145 -14,500 | -0.5% | -$129K |
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $27.1M | 2.1% | 270,800 | – | – |
|
|
MDVN
16
DELISTED
MEDIVATION, INC.
MDVN
| $24.2M | 1.88% | 525,462 +15,600 | +3% | +$717K |
|
|
ENDP
17
DELISTED
Endo International plc
ENDP
| $23.3M | 1.81% | 828,630 +27,400 | +3% | +$771K |
|
|
CEMP
18
DELISTED
Cempra, Inc.
CEMP
| $21.3M | 1.65% | 1,215,833 +40,100 | +3% | +$703K |
|
|
19
STAAR Surgical
STAA
$1.36B
| $19.5M | 1.52% | 2,641,875 -24,847 | -0.9% | -$184K |
|
|
SHPG
20
DELISTED
Shire pic
SHPG
| $18.2M | 1.42% | 106,100 +1,400 | +1% | +$241K |
|
|
ZLTQ
21
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $15.6M | 1.21% | 573,636 | – | – |
|
|
ARIA
22
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $14.4M | 1.12% | 2,248,317 -8,900 | -0.4% | -$56.9K |
|
|
SQNM
23
DELISTED
SEQUENOM INC NEW
SQNM
| $14.1M | 1.1% | 10,023,842 | – | – |
|
|
MNTA
24
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $13.6M | 1.05% | 1,468,776 | – | – |
|
|
25
Acadia Pharmaceuticals
ACAD
$4.38B
| $13.6M | 1.05% | +485,100 | New | +$13.6M |
|